The vial can be kept at room temperature for short periods, such as during travel or immediately before injection, but prolonged exposure to room temperature should be avoided
Shi ZZ, Habib GM, Rhead WJ, Gahl WA, He X, Sazer S, Lieberman MW
Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation
A dermatologist can also identify treatable causes of hair loss thyroid disease, iron deficiency, telogen effluvium and others that no peptide will address
doi: 10.1038/nature03354 49
of Montral received the original Notice of Compliance from Health Canada on April 29, 2014 for the 2 mg/vial Egrifta presentation, followed by a 1 mg/vial supplementary approval in March 2015